Hanson & Doremus Investment Management’s Du Pont De Nemours E I DD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,811
Closed -$227K 510
2017
Q2
$227K Buy
2,811
+342
+14% +$27.3K 0.08% 157
2017
Q1
$198K Hold
2,469
0.08% 165
2016
Q4
$181K Hold
2,469
0.08% 166
2016
Q3
$165K Sell
2,469
-150
-6% -$10.2K 0.08% 169
2016
Q2
$170K Hold
2,619
0.08% 164
2016
Q1
$166K Hold
2,619
0.08% 170
2015
Q4
$174K Hold
2,619
0.08% 169
2015
Q3
$126K Sell
2,619
-139
-5% -$7.42K 0.06% 189
2015
Q2
$167K Hold
2,758
0.07% 176
2015
Q1
$187K Sell
2,758
-2,311
-46% -$165K 0.08% 176
2014
Q4
$356K Hold
5,069
0.15% 139
2014
Q3
$345K Hold
5,069
0.16% 138
2014
Q2
$315K Hold
5,069
0.15% 143
2014
Q1
$323K Hold
5,069
0.15% 141
2013
Q4
$313K Sell
5,069
-357
-7% -$20.6K 0.15% 139
2013
Q3
$302K Buy
5,426
+1,895
+54% +$103K 0.15% 137
2013
Q2
$176K Buy
+3,531
New +$178K 0.1% 156

Other funds holding DD

Hanson & Doremus Investment Management's DD Position: Q3 2017 in Review

Hanson & Doremus Investment Management sold out of Du Pont De Nemours E I (DD) in Q3 2017, closing a stake of 2,811 shares — an estimated $227K sold.

Hanson & Doremus Investment Management first reported a position in DD in Q2 2013 and held it in 17 quarters. The position peaked at $356K in Q4 2014. 16 funds tracked by Wall St. Rank hold DD as of Q3 2017.

  • Hanson & Doremus Investment Management reported no remaining Du Pont De Nemours E I position as of Q3 2017 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 2,811 Du Pont De Nemours E I shares in Q3 2017, an estimated $227K.
  • Hanson & Doremus Investment Management first reported a position in Du Pont De Nemours E I in Q2 2013 and held it in 17 quarters.
  • Hanson & Doremus Investment Management's Du Pont De Nemours E I position peaked at $356K in Q4 2014.
  • 16 funds tracked by Wall St. Rank held Du Pont De Nemours E I as of Q3 2017.

Based on Hanson & Doremus Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.